Lawson launches new study trialing BLES® as treatment for COVID-19
Researchers at Lawson Health Research Institute are investigating the use of bovine lipid extract surfactant suspension (BLES®) for treating severe cases of COVID-19.
What is bovine lipid extract surfactant suspension and what can it do to help patients suffering from the disease caused by the novel coronavirus?
Dr. Jim Lewis, Lawson Scientist and Respirologist at St. Joseph’s Health Care London, joins Craig to discuss.
See omnystudio.com/listener for privacy information.